Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection

Journal of Hepatology

Volumn 66, Issue 2, 2017, Pages 355-362

  Chayanupatkul, Maneerat ^a   Omino, Ronald ^a   Mittal, Sahil ^a,b   Kramer, Jennifer R ^b   Richardson, Peter ^b   Thrift, Aaron P ^a   El Serag, Hashem B ^a,b   Kanwal, Fasiha ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chronic hepatitis B; Cirrhosis; Epidemiology; Hepatocellular carcinoma; Liver cirrhosis; Liver transplantation; Risk factors

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; CANCER RISK; CANCER SURVIVAL; CHRONIC HEPATITIS B; CONTROLLED STUDY; DEMOGRAPHY; DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING; ENDOSCOPY; FAMILY HISTORY; FEMALE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; SURVIVAL; TRANSPLANT FREE SURVIVAL; AGED; ANAMNESIS; COMPLICATION; GOVERNMENT; HEPATITIS B VIRUS; ISOLATION AND PURIFICATION; LIVER TUMOR; MORTALITY; PATHOLOGY; RISK FACTOR; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; UNITED STATES;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DEMOGRAPHY; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; RISK FACTORS; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 85005900893     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2016.09.013     Document Type: Article

References (28)

1. [1] Bosch, F.X., Ribes, J., Diaz, M., Cleries, R., Primary liver cancer: worldwide incidence and trends. Gastroenterology 127 (2004), S5–s16.
2. [2] El-Serag, H.B., Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology, 142, 2012 1264–73.e1.
3. [3] Fattovich, G., Bortolotti, F., Donato, F., Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 48 (2008), 335–352.
4. [4] Bonilla Guerrero, R., Roberts, L.R., The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J Hepatol 42 (2005), 760–777.
5. [5] Chen, C.J., Yang, H.I., Natural history of chronic hepatitis B REVEALed. J Gastroenterol Hepatol 26 (2011), 628–638.
6. [6] Bruix, J., Sherman, M., Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, MD) 53 (2011), 1020–1022.
7. [7] Do, A.L., Wong, C.R., Nguyen, L.H., Nguyen, V.G., Trinh, H., Nguyen, M.H., Hepatocellular carcinoma incidence in noncirrhotic patients with chronic hepatitis B and patients with cirrhosis of all etiologies. J Clin Gastroenterol 48 (2014), 644–649.
8. [8] Sezaki, H., Kobayashi, M., Hosaka, T., Someya, T., Akuta, N., Suzuki, F., et al. Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection. J Gastroenterol 39 (2004), 550–556.
9. [9] Kim, J.M., Kwon, C.H., Joh, J.W., Park, J.B., Lee, J.H., Kim, S.J., et al. Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis. Ann Surg Oncol 21 (2014), 458–465.
10. [10] Agency for Healthcare Research and Quality HCaUPH. CLINICAL CLASSIFICATIONS SOFTWARE (CCS) 2015 2016 [Available from: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/CCSUsersGuide.pdf.
11. [11] Takano, S., Yokosuka, O., Imazeki, F., Tagawa, M., Omata, M., Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology (Baltimore, MD) 21 (1995), 650–655.
12. [12] Wong, G.L., Chan, H.L., Chan, H.Y., Tse, P.C., Tse, Y.K., Mak, C.W., et al. Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment. Gastroenterology 144 (2013), 933–944.
13. [13] Sinclair, M., Roberts, S., Kemp, W., Knight, V., Dev, A., Gow, P., et al. Epidemiology of hepatitis B-associated hepatocellular carcinoma in Victoria. Intern Med J 43 (2013), 501–506.
14. [14] Yang, J.D., Kim, W.R., Coelho, R., Mettler, T.A., Benson, J.T., Sanderson, S.O., et al. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol 9 (2011), 64–70.
15. [15] Ghany, M.G., Perrillo, R., Li, R., Belle, S.H., Janssen, H.L., Terrault, N.A., et al. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol 13 (2015), 183–192.
16. [16] Parkin DM WS, Ferlay J, Teppo L, Thomas DB, editors. Cancer incidence in five continents. Volume VIII. IARC Scientific Publications; 2002(155):1–781.
17. [17] Khalili, M., Lombardero, M., Chung, R.T., Terrault, N.A., Ghany, M.G., Kim, W.R., et al. Diabetes and prediabetes in patients with hepatitis B residing in North America. Hepatology (Baltimore, MD) 62 (2015), 1364–1374.
18. [18] Loomba, R., Liu, J., Yang, H.I., Lee, M.H., Lu, S.N., Wang, L.Y., et al. Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma. Clin Gastroenterol Hepatol, 11, 2013 1636–45.e1-3.
19. [19] Turati, F., Edefonti, V., Talamini, R., Ferraroni, M., Malvezzi, M., Bravi, F., et al. Family history of liver cancer and hepatocellular carcinoma. Hepatology (Baltimore, MD) 55 (2012), 1416–1425.
20. [20] Su, Q., Liu, Y.F., Zhang, J.F., Zhang, S.X., Li, D.F., Yang, J.J., Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Hepatology (Baltimore, MD) 20 (1994), 788–799.
21. [21] Welzel, T.M., Graubard, B.I., Quraishi, S., Zeuzem, S., Davila, J.A., El-Serag, H.B., et al. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol 108 (2013), 1314–1321.
22. [22] Nair, S., Mason, A., Eason, J., Loss, G., Perrillo, R.P., Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?. Hepatology (Baltimore, MD) 36 (2002), 150–155.
23. [23] Chen, C.L., Yang, H.I., Yang, W.S., Liu, C.J., Chen, P.J., You, S.L., et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 135 (2008), 111–121.
24. [24] Chen, V.L., Le, A.K., Kim, N.G., Kim, L.H., Nguyen, N.H., Nguyen, P.P., et al. Effects of cirrhosis on short-term and long-term survival of patients with hepatitis b-related hepatocellular carcinoma. Clin Gastroenterol Hepatol, 14, 2016 887–95.e1.
25. [25] Zhou, Y., Lei, X., Wu, L., Wu, X., Xu, D., Li, B., Outcomes of hepatectomy for noncirrhotic hepatocellular carcinoma: a systematic review. Surg Oncol 23 (2014), 236–242.
26. [26] Di Bisceglie, A.M., Hepatitis B and hepatocellular carcinoma. Hepatology (Baltimore, MD) 49 (2009), S56–S60.
27. [27] Holmberg, S.D., Lu, M., Rupp, L.B., Lamerato, L.E., Moorman, A.C., Vijayadeva, V., et al. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort. Clin Infect Dis 57 (2013), 240–246.
28. [28] Xiao, G., Yang, J., Yan, L., Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology (Baltimore, MD) 61 (2015), 292–302.